期刊文献+

乳腺癌微转移的分子诊断 被引量:2

Molecular diagnosis of micrometastasis in breast cancer
原文传递
导出
摘要 在乳腺癌微转移的诊断中,病理学、免疫组织化学等常规方法敏感性不高,分子诊断学技术特别是逆转录一聚合酶链反应(RT-PCR)在微转移诊断中显示出了独特的优势。目前用于诊断乳腺癌微转移的生物学标记物主要有癌胚抗原、细胞角蛋白、人乳珠蛋白、多形上皮黏蛋白、基质金属蛋白酶、组织蛋白酶D、p53、表皮生长因子受体等。 Pathology, immunohistochemistry and other conventional methods are less sensitive in detection of micrometastasis in breast cancer. Molecular diagnostic technologies in particular reverse transcriptase polymerase chain reaction(RT-PCR) are superior in detection of micrometastasis. Now, the biological marks for breast cancer metastasis include carcinoembryonic antigen, cytokeratin, human mammaglobin, polymorphic epithelial mucin, matrix metalloproteinases, Cath-D, p53, epidermal growth factor recaptor, etc.
出处 《国际肿瘤学杂志》 CAS 2007年第12期923-926,共4页 Journal of International Oncology
关键词 乳腺肿瘤 肿瘤转移 肿瘤标记 生物学 分子诊断技术 逆转录聚合酶链反应 Breast neoplasms Neoplasm metastasis Tumor markers, biological Molecular diagnostic techniques Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献1

二级参考文献14

  • 1Faleiro-Rodrigues C,Lopes C.E-cadherin,CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix:an immunohistochemical study[J].Pathobiology,2004,71 (6):329-336.
  • 2Kobel M,Weichert W,Cruwell K,et al.Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis[J].Virchows Arch,2004,445(5):456-464.
  • 3Nozoe T,Kohnoe S,Ezaki T,et al.Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma[J].J Cancer Res Clin Oncol,2004,130(6):334-338.
  • 4Sobin L H,Wittekind C H.TNM classification of maglignant tumors[M].6 th ed.New York:Wiley-Liss,2002:131-141.
  • 5Heider K H,Kuthan H,Stehle G,et al.CD44v6:a target for antibody-based cancer therapy[J].Cancer Immunol Immunother,2004,53(7):567-579.
  • 6Bankfalvi A,Terpe H J,Breukelmann D,et al.Gains and losses of CD44 expression during breast carcinogenesis and tumour progression[J].Histopathology,1998,33(2):107-116.
  • 7Hefler L,Temfer C,Haeusler G,et al.Cytosol concentrations of CD44 isoforms in breast cancer tissue[J].Int J Cancer,1998,79(5):541-545.
  • 8Ma W,Deng Y,Zhou Y.The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma:a clinicopathologic study[J].Clin Oncol(R Coll Radiol),2005,17(4):258-263.
  • 9Bemer H S,Suo Z,Risberg B,et al.Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas[J].Histopathology,2003,42 (6):546-554.
  • 10Tokue Y,Matsumura Y,Katsumata N,et al.CD44 variant isoform expression and breast cancer prognosis[J].Jpn J Cancer Res,1998,89 (3):283-290.

共引文献7

同被引文献43

  • 1赵长鹰,叶净春.继续医学教育项目实施的途径与方法[J].继续医学教育,2012,26(4):6-9. 被引量:5
  • 2郭建秀,刘秀娜,胡川闽.人乳腺珠蛋白与乳腺癌[J].国际肿瘤学杂志,2006,33(11):831-834. 被引量:3
  • 3McPherson K, Steel CM, Dixon JM. ABC ofbreast diseases : breast cancer epidemiology, risk factors and genetics [ J ]. BMJ,2000,321 (7261) :624.
  • 4Watson MA, Fleming TP. Mammaglobin, amammary-specific member of the uter-oglobin gene family, is overexpressed in human breast cancer [ J ]. Cancer Res, 1996,56 (4) : 860.
  • 5Pier PF, Cristina R, Chiara M, et al. Mam-maglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer[ J]. Clinical Cancer Research,2004,18 ( 1 ) :6039.
  • 6Gimbergues P,Dauplat MM,Cayre A,et al. Correlation between molecular metastases in sentinel lymph nodes of breastcancer patients and St Gallen risk category[J]. Eur J Surg Onco1,2007,33 ( 1 ) : 16.
  • 7lakovlev VV, oswamil RS, Vecchiarelli J, et al. Quantitative detection of circulati-ng epithelial cells by Q-RT-PCR [ J ]. Breast Cancer Res Treat,2008,107( 1 ) :145.
  • 8Livak K J, Schmittgen TD. Analysis of relative gene expression data using reahime quantitative PCR and the 2 (-Delta Delta CT) Method [ J ]. Methods, 2001,25 ( 4 ) : 402.
  • 9Ghaffari SR, Sabokbar T, Tahmasebi S, et al. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers-a molecular study of 59 patients[ J]. Asian Pac J Cancer Prey,2006, 7(3) :396.
  • 10Roncella S, Ferro P, Bacigalupo B, et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheralblood [J]. J Exp Clin Cancer Res ,2005,24 (2) :265.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部